Laxxon Medical is a pharma-technology company pioneering cutting-edge 3D screen printing development and manufacturing solutions for the pharmaceutical industry. It was founded in 2017 by a team of medical and business professionals with 20+ years of experience in the pharmaceutical industry. The company provides comprehensive pharmaceutical services to pharmaceutical partners, including R&D, IP, and regulatory services.

Laxxon Medical

Laxxon is a pharma-technology company pioneering a new generation of advanced pharmaceuticals with SPID®, a novel 3D screen printing platform technology. From common pharmaceutical drugs to new drug developments, SPID® unlocks innovative drug delivery advancements paired with 
fast-tracked market access and extensive IP protection to yield disruptive opportunities for partners, healthcare providers, and patients. 

Laxxon’s diverse product pipeline is continuously growing and consists of 13 in-house Advanced Patented Generics, in addition to multiple ongoing working-projects with notable pharmaceutical players, biotech organizations and research universities.

Our CSO, Dr. Achim Schneeberger, shares his excitement on the development process made possible by our SPID®-Technology.

Learn more from Laxxon's leadership in the full interview: https://lnkd.in/eNhiv75c

#pharmaceutical #3dprinting #3dprintingtechnology #medicalinnovation #medicaltechnology #medicaltech

Drug Delivery Systems (DDS) technologies play a pivotal role in precise drug targeting, minimizing side effects and enhancing medicine's precision.

But what are DDS' exactly? What do they do? And how do you know which type of DDS best suits your pharmaceutical needs?

Check out our video and our blog to learn more: https://lnkd.in/gBvPGUyw

#pharmaceutical #3dprinting #3dprintingtechnology #medicalinnovation #medicaltechnology #medicaltech

We're honored that our very own CSO, Alex Ruckdaeschel, is featured in this BioSpectrum Asia article.

Their coverage of the Life Science trends that are poised to influence the industry in 2024 are insightful and exciting as we continue to push forward in the innovation of pharmaceuticals.

Read more in the full article here: https://lnkd.in/eMTZxi6Y

And visit our website to learn more about Laxxon's innovative technology: https://lnkd.in/dmQvYurx

#pharmaceutical #3dprinting #3dprintingtechnology #medicalinnovation #medicaltechnology #medicaltech

2024 is shaping up to be a landmark year in life sciences, with 3D printing leading the charge. 

At Laxxon Medical, we're proud to be at the forefront of this revolution.

Our patented SPID®-Technology is not just about creating drugs; it's about redefining pharmaceutical production and delivery. 

As the industry shifts towards personalized medicine, our 3D-printed drugs are set to transform patient care, offering tailored drug delivery and programmed release.

Learn more about our pharmaceutical solutions by visiting our website: https://lnkd.in/dmQvYurx

#pharmaceutical #3dprinting #3dprintingtechnology #medicalinnovation #medicaltechnology #medicaltech

Through our unique SPID®-Technology, our additive manufacturing approach allows for the optimization and reformulation of such pharmaceutical products which, in turn, are protected by the Laxxon IP, while also addressing common generic drug issues such as patient compliance, dosage, and side effects.

Learn more about our patent extension process by visiting us: https://lnkd.in/dmQvYurx

#pharmaceutical #3dprinting #3dprintingtechnology #medicalinnovation #medicaltechnology #medicaltech

In the realm of highly regulated environments, maintaining a sense of flexibility may seem contradictory, yet it can prove to be a pivotal factor. 

Regulations are put in place to establish strict guidelines for manufacturing processes, ensuring the reliability, effectiveness, and safety of regulated products. 

However, fostering agility within operations allows leaders to swiftly adapt and seize new opportunities that arise, whether anticipated or unforeseen. 

By enhancing flexibility, businesses can navigate the ever-changing landscape and make the most of changing circumstances. 

Embracing this mindset can be a game-changer, enabling organizations to thrive in the face of stringent regulations. 

This article covers more insights on how to introduce efficiency and agility to meet regulations in the most productive and profitable ways: https://lnkd.in/gwTFBN-8

#pharmaceutical #3dprinting #3dprintingtechnology #medicalinnovation #medicaltechnology #medicaltech

What is First-Pass Metabolism, and why is it important?

In our blog on the topic, we explore the First-Pass effect, how it effects how we take medications, and some solutions to the issue, including adventuring into the realm of personalized medication.

Learn more by visiting us today: https://lnkd.in/eXdegDNY

#pharmaceutical #3dprinting #3dprintingtechnology #medicalinnovation #medicaltechnology #medicaltech

We're thrilled to be participating in the 26th Annual Needham & Company Growth Conference.

Our CEO Helmut Kerschbaumer and CSO Alexander Ruckdaeschel will participate in one-on-one meetings with institutional, private equity, and venture capital investors while there.

Learn more in our announcement here: https://lnkd.in/gmiQwk9S

#pharmaceutical #3dprintingindustry #3dprinting #3dprintingtechnology #medicalinnovation #medicaltechnology

Ringing in the new year, our CSO Alex Ruckdaeschel speaks on moving forward in the industry with an open mind to new technology in an industry ever-growing.

Learn more about 2024 Transformative Life Science Trends in BioSpectrum Asia's latest article featuring Laxxon:  
https://lnkd.in/eMTZxi6Y


#pharmaceutical #3dprinting #3dprintingtechnology #medicalinnovation #medicaltechnology #medicaltech

Regrettably, medication errors are an unfortunate reality in today's world.

The increasing prevalence of prescription medications and patients juggling multiple similar-looking drugs creates a breeding ground for mistakes.

Our blog delves into this disconcerting issue, exploring the primary culprits behind medication errors and offering potential solutions: https://lnkd.in/dNB5HpvC

#pharmaceutical #3dprinting #3dprintingtechnology #medicalinnovation #medicaltechnology #medicaltech

COM:LAXXONMEDICAL

Laxxon Medical

locale

market

industry

website

linkedin

founding date

peer of

Metrics